Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

BACKGROUND: The relapse rate in early stage non-small cell lung cancer (NSCLC) after surgical resection is high. Prognostic biomarkers may help identify patients who may benefit from additional therapy. The Helicase-like Transcription Factor (HLTF) is a tumor suppressor, altered in cancer either by...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhont, Ludovic, Pintilie, Melania, Kaufman, Ethan, Navab, Roya, Tam, Shirley, Burny, Arsène, Shepherd, Frances, Belayew, Alexandra, Tsao, Ming-Sound, Mascaux, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902896/
https://www.ncbi.nlm.nih.gov/pubmed/29661164
http://dx.doi.org/10.1186/s12885-018-4215-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902896/
https://www.ncbi.nlm.nih.gov/pubmed/29661164
http://dx.doi.org/10.1186/s12885-018-4215-y

Ejemplares similares